A swipe-through explainer covering how each drug works, common side effects and trial results, noting the trials were separate, not head to head.
Recap by typeshit. Post by @figurelabs.ai on Instagram.
Researchers are starting to explain the shifts in libido some GLP-1 users report. The full story covers what scientists have found so far.
Bikman says the added glucagon receptor push raises energy use and liver fat burning, and points to 24.2% weight loss on 12 mg in phase 2.
9:08
Archibald takes on a common question about low retatrutide doses and the drug's glucagon action. His view, not settled science, and retatrutide is still unapproved.
A report says an Eli Lilly drug helped protect muscle mass when combined with Novo's Wegovy, addressing a common worry about lean mass loss.
A guide covers who qualifies for the lower price, how to bring it up with a doctor, and delivery options that cut costs further.
Industry executives say India's contract drug makers are moving past cheap small molecules into more complex products, including peptides.
Loading…